The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

DSGN FINANCIAL STATEMENTS

Design Therapeutics Inc — balance sheet, income statement and cash flow trends

DSGNDesign Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-75 M-50 M-25 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit152 K $ · Infinity%Operating Income-79.4 M $ · -Infinity%Pre-tax Income-70.8 M $ · -Infinity%Net Income to Owners-70.8 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $-100.0%
Gross Profit152 K $—
Operating Income-79.4 M $—
EBITDA-72.3 M $—
Net Income to Owners-70.8 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets215.1 M
  • Equity201.9 M $94%
  • Current Liabilities11.2 M $5%
  • Long-term Liabilities2 M $1%

Key Figures

YoY change
Total Assets215.1 M $-3.5%
Total Liabilities13.3 M $+34.7%
Total Equity201.9 M $-5.2%
Cash & ST Investments207.4 M $-4.1%
Total Debt2 M $+4.4%
Net Debt-10.9 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-60 M-40 M-20 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-40 M-20 M0-55.1 M $Operating2.4 M $Investing45.9 M $Financing-6.8 M $Net Change

Key Figures

YoY change
Operating Cash Flow-55.1 M $—
Capital Expenditures55 K $-68.6%
Free Cash Flow-55.1 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on DSGN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.